Ohio State Navbar

People

Abhay Satoskar, PhD


Staff photo

320 W 10th Ave
Columbus, OH 43210

Phone: (614) 292-3243

Email: satoskar.2@osu.edu

 

Current OSU Appointment

Professor, Pathology

 

Advising Narrative

Biological Sciences 2005 Denman Undergrad Research Forum: 1st Place Biological Sciences2006 College of Biological Sciences Undergrad Research Colloquium participant2006 Denman Undergrad Research Forum: 3rd Place Biological Sciences2006 College of Biological Sciences Undergrad Research Colloquium participant Biological Sciences Biological Sciences 2006 Denman Undergraduate Research Forum4th Place - Biological Sciences2006 College of Biological Sciences Undergrad Research Colloquium participant 2007 McGraw-Hill for outstanding research, Central Ohio (High school)2007 First Place, Biology Teachers Award, State of Ohio (High school)2007 First Place, Future Physician-Scientist Award, State of Ohio (High school)2007 Fourth Place for Science and Medicine, International INTEL ISEF Competition 2008 Denman Undergrad Research Forum: 1st Place Biological Sciences2008 College of Biological Sciences Undergrad Research Colloquium participant

Books

Multiple. Medical Parasitology. Austin, TX: Landes Bioscience, January 2009.

 

Certifications

1989 - present General Physician: Maharashtra Medical Council
 

Chapters in Books

Alexander J, Jebbari H, Bluethmann H, Satoskar AR, Roberts CW. "Immunological Control of Toxoplasma gondii and Appropriate Vaccine Design." In Current Topics in Microbiology and Immunology. Edited by Gross U. 183-. London: Springer, January 1996.

Alexander J, Satoskar AR. "Leishmaniasis: Does Interleukin-13 (IL-13) Play a Significant Role in the Disease Process?." In Interleukin-13. Edited by Brombacher F. -. Austin: Landes Bioscience, January 2002.

Fingerle-Rowson G, Satoskar AR, Bucala R. "Macrophage Migration Inhibitory Factor (MIF)-Deficient Mice." In Cytokine Knockouts. Edited by Fantuzzi G. -. Newark: Humana Press, January 2002.

Snider H, Lezama-Davila C, Terrazas LI, Satoskar AR. "MIF in Parasitic and Helmithic Infections." In MIF: A Most Interesting Factor. Edited by Bucala R. -. Singapore: World Scientific Publishing/Imperial College Press, January 2006.

Lezama-Davila CM, Issac-Marquez AP, Satoskar AR. "Immunoregulation of Chiclero’s Ulcer." In Advances in the Immunobiology of Parasitic Diseases. Edited by Terrazas L. -. Trivendrum, IN|IND: Research Signpost, January 2008.

Barbi J, Snider HM, Satoskar AR. "The Role of Chemokines in Leishmaniasis." In Advances in the Immunobiology of Parasitic Diseases. Edited by Terrazas L. -. Trivendrum, IN|IND: Research Signpost, January 2008.

Lezama-Davila CM, David JR, Satoskar AR. "Cutaneous Leishmanaisis." In Medical Parasitology. Edited by Satoskar AR, Simon G, Tsuji M, Hotez P. -. Austin: Landes Bioscience, January 2009.

Cummings H, Terrazas LI, Satoskar AR. "Taeniasis and Cysticercosis." In Medical Parasitology. Edited by Satoskar AR, Simon G, Tsuji M, Hotez P. -. Austin: Landes Bioscience, January 2009.

Satoskar AR, Snider HM, Alexander J. "Sex Differences in Response to Parasites." In Sex Hormones and Immunity to Infection. Edited by Klein S, Roberts C. -. Heidelberg, DE|DEU: Springer, January 2009.

Cummings H, Rodriguez-Sosa M, Satoskar AR. "Hydatid Disease." In Medical Parasitology. Edited by Satoskar AR, Simon G, Tsuji M, Hotez P. -. Austin: Landes Bioscience, January 2009.

 

Conferences

Wang BP, Nguyen K, Zhang XM, Stamm L, David J, Satoskar A, Biron C. "Use of a novel natural killer cell deficiency mouse model to evaluate role for NK cells in shaping adoptive immune responses during parasitic and viral infections." In FASEB JOURNAL. (March 1998). A904-.

Satoskar A, Stamm L, David J, Terhorst C, Wang BP. "Essential role of natural killer cells in regulating IgG2a production in vivo revealed in a novel murine model of specific NK cell deficiency." In FASEB JOURNAL. (March 1998). A907-.

Greenwald RJ, McAdam AJ, van der Woude D, Satoskar AR, Sharpe AH. "Inducible costimulator protein (ICOS) regulates both Th1 and Th2 responses to cutaneous leishmaniasis." In FASEB JOURNAL. (March 2002). A301-.

Terrazas LI, Satoskar AR, Tena CA, Graullera V, Rodriguez-Sosa M. "Stat-4 mediated IL-12 signaling pathway is critical for development of protective immunity in experimental cysticercosis." In FASEB JOURNAL. (April 2003). C197-.

Satoskar AR, Rosas LE, Durbin JE. "STAT1-mediated IFN-signaling pathway is indispensable for the development of protective immunity against cutaneous leishmaniasis." In FASEB JOURNAL. (April 2003). C55-.

Rodriguez-Sosa M, Satoskar AR, David JR, Monteon-Padilla V, Gomez-Garcia L, Tena CA, Graullera V, Terrazas LI. "Macrophage migration inhibitory factor plays a role in acute trypanosoma cruzi infection." In FASEB JOURNAL. (April 2003). C195-.

Damico N, Satoskar AR, David JR, Whitacre CC. "Macrophage migration inhibitory factor (MIF) plays a role in the relapses of experimental autoimmune encephalomyelitis (EAE)." In FASEB JOURNAL. (April 2003). C45-.

Pan JH, Sukhova GK, Yang JT, Fu HX, Bing W, Yaou Z, Bucala R, Satoskar AR, David JR, Metz C, Shi GP. "Macrophage migration inhibitory factor involves in atherosclerosis by regulating matrix-degrading cysteine protease and metalloprotease expression." In CIRCULATION. (October 2003). 26-.

Whitacre C, Damico N, Satoskar A, Papenfuss T, McClain M, Shawler T, Gienapp I. "Critical role for macrophage migration inhibitory factor (MIF) in the relapses of experimental autoimmune encephalomyelitis (EAE)." In JOURNAL OF NEUROIMMUNOLOGY. (September 2004). 53-.

Isaza CE, Zhong XJ, Arndt J, White J, Rosas L, Satoskar A, Chan M. "Integrated studies on the M32 family of carboxypeptidases: structural, mechanistic and functional insights." In BIOPHYSICAL JOURNAL. (January 2004). 488A-.

Isaza C, Zhong XJ, Arndt J, White J, Rosas L, Satoskar A, Chan M. "Integrated studies on the M32 family of carboxypeptidases: structural, mechanistic and functional insights." In FASEB JOURNAL. (May 2004). C239-.

Satoskar A, Rosas L, Barbi J, deSauvage F, Hunter C, Roth K, Satoskar A. "IL-27R (WSX-1/TCCR) gene deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology." In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. (December 2005). 38-.

Rosas L, Keiser T, Barbi J, Septer A, Kaczmarek J, Satoskar AR. "Genetic differences in host susceptibility of mice to Leishmania mexicana revealed in a low dose ear infection model." In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. (December 2005). 365-366.

Satoskar AR, Rosas L, Satoskar AA, Barbi J, Pappenfuss T, Keiser T, Durbin J. "Stat-1 deficiency increases host resistance and reduces hepatic immunopathology during visceral Leishmaniasis." In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. (December 2005). 329-.

Satoskar A, Zorko N, Keiser T, Barbi J, Lu B, Gerard C. "Role PI-3 Gamma in pathogenesis of cutaneous leishmaniasis caused by L-mexicana." In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. (November 2006). 278-279.

Satoskar A, Barbi J, Rosas L, Carlson T, Lu B, Gerard C. "The chemokine receptor CXCR3 is not required for host resistance to murine visceral leishmaniasis." In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. (November 2006). 242-.

Satoskar A, Snider H, Barbi J, Rosas L, Durbin J. "STAT1 plays distinct role in determining outcome of L-donovani infection in C57BL/6 and BALB/c mice." In AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. (November 2006). 198-.

Barbi J, Oghumu S, Rosas LE, Carlson T, Lu B, Gerard C, Lezama-Davila CM, Satoskar AR. "Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani." In JOURNAL OF INFECTIOUS DISEASES. (June 2007). 1713-1717.

Cummings HE, Barbi J, Keiser T, Zorko N, Lu B, Gerard C, Ruckle T, Seveau S, Rommel C, Whitacre C, Satoskar A. "Targeting phosphoinositide 3-kinase gamma (PI3K gamma) in the treatment of cutaneous leishmaniasis caused by L. mexicana." In FASEB JOURNAL. (April 2008). 1-.

Smith K, Gatson NT, Williams J, Kithcart A, Mavrikis G, Song FF, Satoskar A, Whitacre CC. "PI3K-gamma: Developing immune targets for the treatment of multiple sclerosis." In JOURNAL OF NEUROIMMUNOLOGY. (October 2008). 239-240.

Whitacre C, Williams JL, Cox GM, Smith KM, Kithcart A, Shawler T, Satoskar A. "CNS-immune interactions: External influences as therapeutic interventions." In JOURNAL OF NEUROIMMUNOLOGY. (November 2010). 148-.

Sanchez-Zamora Y, Terrazas LI, Leal E, Juarez I, Selecki T, Satoskar AR, Rodriguez-Sosa M, Vilches-Flores A. "The Role of Macrophage Migration Inhibitory Factor (MIF) as a Novel Therapeutic Target for Diabetes Treatment." In DIABETES. (June 2010). A363-A364.

Abdelhamid D, Pan L, Kinghorn D, Lezama-Davila CM, Satoskar A, Fuchs JR. "Discovery and synthetic development of novel sterols as antileishmanial agents." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (August 2010). 1-.

Mavrikis CG, Alexander J, Kithcart A, Williams J, Smith K, Shawler T, Satoskar A, Whitacre CC. "Macrophage migration inhibitory factor promotes central nervous system pathology in a model of neuroinflammation." In JOURNAL OF NEUROIMMUNOLOGY. (November 2010). 59-.

Abdelhamid D, Pan L, Lezama-Davila CM, Satoskar AR, Kinghorn AD, Fuchs JR. "Synthesis and modification of natural sterols possessing antileishmanial activity." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (March 2012). 1-.

Oghumu S, Dong R, Shawler T, Kampfrath T, Rajagopalan S, Sharpe A, Satoskar A. "Generation and characterization of a CXCR3-EGFP bicistronic reporter (CIBER) mouse reveals phenotypically and functionally distinct populations of innate CD8+T cells." In JOURNAL OF IMMUNOLOGY. (May 2012). 1-.

Pan L, Lezama-Davila CM, Isaac-Marquez AP, Fuchs JR, Satoskar AR, Kinghorn AD. "Compounds with antileishmanial activity isolated from the stems of Pentalinon andrieuxii." In PLANTA MEDICA. (August 2012). 1198-.

Snider H, Gupta G, Satoskar A. "Differential roles for Th1 transcription factors STAT1 and STAT4 during visceral leishmaniasis." In JOURNAL OF IMMUNOLOGY. (May 2012). 1-.

Pan L, Terrazas C, Lezama-Davila CM, Rege N, Gallucci JC, Satoskar AR, Kinghorn AD. "Cordifolide A, a sulfur-containing clerodane diterpene glycoside from Tinospora cordifolia." In PLANTA MEDICA. (August 2012). 1198-.

Fuchs JR, Abdelhamid D, Schwartz EB, Pan L, Naman B, Satoskar AR, Kinghorn AD. "Synthesis of sterols with antileishmanial activity from Pentalinon andrieuxii." In PLANTA MEDICA. (August 2012). 1286-.

Naman CB, Gupta G, Lezama-Davila CM, Doskotch RW, Satoskar AR, Kinghorn AD. "Antileishmanial activity of bisbenzylisoquinoline alkaloids from the genus Thalictrum." In PLANTA MEDICA. (August 2012). 1103-.

Terrazas LI, Terrazas CA, Ledesma-Soto Y, Callejas B, Espinoza-Jimenez A, Bonifaz L, Satoskar AR. "Regulation of inflammatory diseases by cestode antigens: multiple receptors and a possible common pathway." In JOURNAL OF IMMUNOLOGY. (May 2013). 1-.

 

Degrees

1989 M.D., University of Bombay

1992 Ph.D., University of Strathclyde

 

Editorial Activities

1999 - present Memorias Do Instituto Oswaldo Cruz
1999 - 2008 The Journal of Immunology
2000 - present Transactions of the Royal Society of Tropical Medicine and Hygiene
2003 - present Immunology
2003 - present Cellular Immunology
2004 - present International Immunology
2004 - present Parasite Immunology
2004 - present Nitric oxide: Biology and Chemistry
2004 - present Trends in Parasitology
2004 - present Clinical and Experimental Immunology
2005 - present Clinical Infectious Diseases
2005 - present Brain, Behavior and Immunity
2005 - present American Journal of Respiratory & Critical Care Medicine
2005 - present Immunology Letters
2005 - present Laboratory Investigation
2005 - present Experimental Parasitology
2005 - present Infection and Immunity
2005 - 2009 The Journal of Infectious Diseases
2006 - present Microbes and Infection
2006 - present Vaccine
2007 - present The Open Parasitology Journal
2007 - present The Journal of Leukocyte Biology
2007 - present The Journal of Experimental Medicine
2007 - present The FASEB Journal
2007 - present Liver International
2007 - present Cytokine
2007 - present Phytochemistry
2007 - present BMC Infectious Diseases
2007 - present BMC Immunology
2007 - present Journal of Gerontology
2007 - present Case Reports in Medicine
2008 - present Journal of Biomedicine and Biotechnology
2008 - present Proceedings of the National Academy of Sciences USA
2008 - present Asian Pacific Journal of Tropical Medicine
2008 - present The Journal Immunology
2008 - present Molecular and Biochemical Parasitology
2009 - present Nephrology Dialysis Transplantation
2009 - present British Journal of Dermatology
2009 - present PLoS Pathogens
2009 - present American Journal of Physiology Cell Physiology
2009 - present Journal of Investigative Dermatology
2009 - present FEBS Letters
2009 - present Faculty of 1000 Biology
2009 - present Antimicrobial Agents and Chemotherapy
2010 - present Experimental Parasitology
 

Honors

1990 - 1992 University Merit Scholarship. University of Bombay.
1992 Dr. C. K. Deshpande Gold Medal. University of Bombay.
1992 Rameshwardas Birla Trust Scholarship. Rameshwardas Birla Trust.
1992 - 1996 David Livingston Bursary. University of Strathclyde.
1992 - 1996 Overseas Research Student Award. Committee of Vice Chancellors and Principals of UK, London.
1993 Travel Award. British Section of Society for Protozoology.
1995 Travel Award. Scuola Superiore D'Immunologia Ruggero Ceppellini, Positano, Italy.
1996 Travel Award. Britis Section of Society for Protozoology.
2000 Visiting Guest Lecturer. University of Cape Town.
2002 Visiting Scientist Award. University of Cape Town.
2003 American Association of Immunologists Junior Faculty Travel Award. American Association of Immunologists.
2005 Dean's Award for Undergraduate Research Mentoring. Ohio State University, College of Biological Sciences.
 

Journal Articles

Goel A, Pandya SK, Satoskar AR. "Whither short-course chemotherapy for tuberculous meningitis." NEUROSURGERY. Vol. 27, no. 3. (September 1990.): 418-421.

Goel A, Satoskar AR, Nagpal RD, Desai AP. "Intracranial ectopic pituitary tumour." BRITISH JOURNAL OF NEUROSURGERY. Vol. 4, no. 4. (January 1990.): 339-342.

Satoskar AR, Goel A, Desai AP, Usgaonkar TA. "Intracranial hemorrhage and death after iohexol myelography." JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. Vol. 54, no. 12. (December 1991.): 1118-1119.

Satoskar A, Ray V. "Prevalence of Hepatitis-B surface antigen (HBSAG) in blood donors from Bombay." TROPICAL AND GEOGRAPHICAL MEDICINE. Vol. 44, no. 1-2. (January 1992.): 119-121.

Mehta HJ, Ramakantan R, Piparia DH, Hande AM, Goel A, Satoskar AR, Dastur FD. "Clinical implications of acute cerebrospinal fluid changes following iophendylate myelography." JOURNAL OF POSTGRADUATE MEDICINE. Vol. 38, no. 1. (January 1992.): 10-12.

Goel A, Satoskar A, Desai AP, Pandya SK. "Brain abscess caused by cladosporium-trichoides." BRITISH JOURNAL OF NEUROSURGERY. Vol. 6, no. 6. (January 1992.): 591-593.

Satoskar A, Vora IM. "Incidence of helicobacter-pylori-associated gastritis in the urban population from India." TROPICAL AND GEOGRAPHICAL MEDICINE. Vol. 46, no. 3. (January 1994.): 167-168.

McCall DLC, Alexander J, Barber J, Jaouhari RG, Satoskar A, Waigh RD. "The 1st protoberberine alkaloid analog with in-vivo antimalarial activity." BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. Vol. 4, no. 14. (July 1994.): 1663-1666.

Goel A, Bhayani R, Satoskar A, Nagpal RD. "Massive nasopharyngeal carcinoma mimicking garcins syndrome." NEUROLOGY INDIA. Vol. 43, no. 2. (June 1995.): 120-121.

Garside P, Steel M, Worthey EA, Satoskar A, Alexander J, Bluethmann H, Liew FY, Mowat AM. "T-helper-2 cells are subject to high-dose oral tolerance and are not essential for its induction." JOURNAL OF IMMUNOLOGY. Vol. 154, no. 11. (June 1995.): 5649-5655.

Satoskar A, Alexander J. "Sex-determined susceptibility and differential IFN-gamma and TNF-alpha messenger-RNA expression in DBA/2 Mice infected with leishmania-Mexicana." IMMUNOLOGY. Vol. 84, no. 1. (January 1995.): 1-4.

Satoskar A, Bluethmann H, Alexander J. "Disruptionn of the murine interleukin-4 gene inhibits disease progression during leishmania-Mexicana infection but does not increase control of leishmania-Donovani infection." INFECTION AND IMMUNITY. Vol. 63, no. 12. (December 1995.): 4894-4899.

Roberts CW, Satoskar A, Alexander J. "Sex steroids, pregnancy-associated hormones and immunity to parasitic infection." PARASITOLOGY TODAY. Vol. 12, no. 10. (October 1996.): 382-388.

Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J. "In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 26, no. 9. (September 1996.): 2062-2066.

Alexander J, Jebbari H, Bluethmann H, Satoskar A, Roberts CW. "Immunological control of Toxoplasma gondii and appropriate vaccine design." TOXOPLASMA GONDII. Vol. 219, (January 1996.): 183-195.

Roberts CW, Ferguson DJP, Jebbari H, Satoskar A, Bluethmann H, Alexander J. "Different roles for interleukin-4 during the course of Toxoplasma gondii infection." INFECTION AND IMMUNITY. Vol. 64, no. 3. (March 1996.): 897-904.

Raisanen-Sokolowski A, Mottram PL, Glysing-Jensen T, Satoskar A, Russell ME. "Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice - Recipient environment alters graft rejection." JOURNAL OF CLINICAL INVESTIGATION. Vol. 100, no. 10. (November 1997.): 2449-2456.

Satoskar A, Brombacher F, Dai WJ, McInnes I, Liew FY, Alexander J, Walker W. "SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis." JOURNAL OF IMMUNOLOGY. Vol. 159, no. 10. (November 1997.): 5005-5013.

Satoskar A, Okano M, David JR. "gamma delta T cells are not essential for control of cutaneous Leishmania major infection in genetically resistant C57BL/6 mice." JOURNAL OF INFECTIOUS DISEASES. Vol. 176, no. 6. (December 1997.): 1649-1652.

Stamm LM, Raisanen-Sokolowski A, Okano M, Russell M, David JR, Satoskar AR. "Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis." JOURNAL OF IMMUNOLOGY. Vol. 161, no. 11. (December 1998.): 6180-6188.

Satoskar AR, Okano M, Connaughton S, Raisanen-Sokolwski A, David JR, Labow M. "Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 28, no. 7. (July 1998.): 2066-2074.

Satoskar A, Al-Quassi HHK, Alexander J. "Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice." IMMUNOLOGY AND CELL BIOLOGY. Vol. 76, no. 2. (April 1998.): 159-166.

Bozza M, Soares MBP, Bozza PT, Satoskar AR, Diacovo TG, Brombacher F, Titus RG, Shoemaker CB, David JR. "The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 28, no. 10. (October 1998.): 3120-3127.

Xu DM, McSorley SJ, Tetley L, Chatfield S, Dougan G, Chan WL, Satoskar A, David JR, Liew FY. "Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium." JOURNAL OF IMMUNOLOGY. Vol. 160, no. 3. (February 1998.): 1285-1289.

Okano M, Nishizaki K, Satoskar AR, Yoshino T, Masuda Y, Harn DA. "Involvement of carbohydrate on phospholipase A(2), a bee-venom allergen, in in vivo antigen-specific IgE synthesis in mice." ALLERGY. Vol. 54, no. 8. (August 1999.): 811-818.

Stamm LM, Satoskar AA, Ghosh SK, David JR, Satoskar AR. "STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 29, no. 8. (August 1999.): 2524-2529.

de Jong YP, Comiskey M, Satoskar AR, Lin G, David GR, Terhorst C. "Macrophage migration inhibitory factor plays a protective role in murine acute experimental colitis." IMMUNOLOGY LETTERS. Vol. 69, no. 1. (January 1999.): 130-131.

Alexander J, Satoskar AR, Russell DG. "Leishmania species: Models of intracellular parasitism." JOURNAL OF CELL SCIENCE. Vol. 112, no. 18. (January 1999.): 2993-3002.

Okano M, Nishizaki K, Nakada M, Kawarai Y, Goto S, Satoskar AR, Satoskar AA, Takehisa T, Masuda Y. "Prevalence and prediction of allergic rhinitis using questionnaire and nasal smear examination in schoolchildren." ACTA OTO-LARYNGOLOGICA. Vol. 540, (January 1999.): 58-63.

Satoskar AR, Stamm LM, Zhang XM, Okano M, David JR, Terhorst C, Wang BP. "NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response." JOURNAL OF IMMUNOLOGY. Vol. 163, no. 10. (November 1999.): 5298-5302.

Okano M, Satoskar AR, Nishizaki K, Abe M, Harn DA. "Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens." JOURNAL OF IMMUNOLOGY. Vol. 163, no. 12. (December 1999.): 6712-6717.

Satoskar AR, Stamm LM, Zhang XM, Satoskar AA, Okano M, Terhorst C, David JR, Wang BP. "Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection." JOURNAL OF IMMUNOLOGY. Vol. 162, no. 11. (June 1999.): 6747-6754.

Okano M, Nishizaki K, Abe M, Wang MM, Yoshino T, Satoskar AR, Masuda Y, Harn DA. "Strain-dependent induction of allergic rhinitis without adjuvant in mice." ALLERGY. Vol. 54, no. 6. (June 1999.): 593-601.

Bozza M, Satoskar AR, Lin GS, Lu B, Humbles AA, Gerard C, David JR. "Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis." JOURNAL OF EXPERIMENTAL MEDICINE. Vol. 189, no. 2. (January 1999.): 341-346.

Pien G, Satoskar AR, Takeda K, Akira S, Biron CA. "Cutting edge: Selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection." JOURNAL OF IMMUNOLOGY. Vol. 165, no. 9. (November 2000.): 4787-4791.

Satoskar AR, Rodig S, Telford SR, Satoskar AA, Ghosh SK, von Lichtenberg F, David JR. "IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 30, no. 3. (March 2000.): 834-839.

Okano M, Satoskar AR, Abe M, Harn DA, Okano M, Nishizaki K, Takeda Y, Yoshino T, Brombacher F, Satoskar AA. "Interleukin-4-independent production of Th2 cytokines by nasal lymphocytes and nasal eosinophilia in murine allergic rhinitis." ALLERGY. Vol. 55, no. 8. (August 2000.): 723-731.

Satoskar AR, ELizondo J, Monteforte GM, Stamm LM, Bluethmann H, Katavolos P, Telford SR. "Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection." FEMS MICROBIOLOGY LETTERS. Vol. 183, no. 2. (February 2000.): 319-325.

Dhabhar FS, Satoskar AR, Bluethmann H, David JR, McEwen BS. "Stress-induced enhancement of skin immune function: A role for gamma interferon." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Vol. 97, no. 6. (March 2000.): 2846-2851.

Alexander J, Carter K, Al-Fasi N, Satoskar A, Brombacher F. "Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 30, no. 10. (October 2000.): 2935-2943.

Monteforte GM, Takeda K, Rodriguez-Sosa M, Akira S, David JR, Satoskar AR. "Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection." JOURNAL OF IMMUNOLOGY. Vol. 164, no. 11. (June 2000.): 5890-5893.

Rodriguez-Sosa M, Monteforte GM, Satoskar AR. "Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness." IMMUNOLOGY AND CELL BIOLOGY. Vol. 79, no. 4. (July 2001.): 320-322.

Okano M, Satoskar AR, Nishizaki K, Harn DA. "Lacto-N-fucopentaose III found on Schitosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response." JOURNAL OF IMMUNOLOGY. Vol. 167, no. 1. (July 2001.): 442-450.

Satoskar AR, Bozza M, Sosa MR, Lin GS, David JR. "Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection." INFECTION AND IMMUNITY. Vol. 69, no. 2. (February 2001.): 906-911.

Yu LCH, Yang PC, Berin MC, Di Leo V, Conrad DH, McKay DM, Satoskar AR, Perdue MH. "Enhanced transepithelial antigen transport in intestine of allergic mice is mediated by IgE/CD23 and regulated by interleukin-4." GASTROENTEROLOGY. Vol. 121, no. 2. (August 2001.): 370-381.

Hattori H, Okano M, Yoshino T, Akagi T, Nakayama E, Saito C, Satoskar AR, Ogawa T, Azuma M, Nishizaki K. "Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis." CLINICAL AND EXPERIMENTAL ALLERGY. Vol. 31, no. 8. (August 2001.): 1242-1249.

Wu CB, Nguyen KB, Pien GC, Wang NH, Gullo C, Howie D, Sosa MR, Edwards MJ, Borrow P, Satoskar AR, Sharpe AH, Biron CA, Terhorst C. "SAP controls T cell responses to virus and terminal differentiation of T(H)2 cells." NATURE IMMUNOLOGY. Vol. 2, no. 5. (May 2001.): 410-414.

Yamamoto T, Okano M, Ono T, Nakayama E, Yoshino T, Satoskar AR, Harn DA, Nishizaki K. "Sex-related differences in the initiation of allergic rhinitis in mice." ALLERGY. Vol. 56, no. 6. (June 2001.): 525-531.

Sosa MR, Rosas LE, McKenzie ANJ, Satoskar AR. "IL-13 gene-deficient mice are susceptible to cutaneous L-mexicana infection." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 31, no. 11. (November 2001.): 3255-3260.

Okano M, Azuma M, Yoshino T, Hattori H, Nakada M, Satoskar AR, Harn DA, Nakayama E, Akagi T, Nishizaki K. "Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice." AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. Vol. 164, no. 8. (October 2001.): 1501-1507.

De Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M, ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P, van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C. "Development of chronic colitis is dependent on the cytokine MIF." NATURE IMMUNOLOGY. Vol. 2, no. 11. (November 2001.): 1061-1066.

Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. "A unique mechanism for innate cytokine promotion of T cell responses to viral infections." JOURNAL OF IMMUNOLOGY. Vol. 169, no. 10. (November 2002.): 5827-5837.

Rodriguez-Sosa M, Satoskar AR, Calderon R, Gomez-Garcia L, Saavedra R, Bojalil R, Terrazas LI. "Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability." INFECTION AND IMMUNITY. Vol. 70, no. 7. (July 2002.): 3656-3664.

Brown JA, Greenwald RJ, Scott S, Schweitzer AN, Satoskar AR, Chung C, Schopf LR, van der Woude D, Sypek JP, Sharpe AH. "T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 32, no. 6. (June 2002.): 1764-1772.

Szabo SJ, Sullivan B, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. "Distinct effects of T-bet in T(H)1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells." SCIENCE. Vol. 295, no. 5553. (January 2002.): 338-342.

Parish CL, Finkelstein DI, Tripanichkul W, Satoskar AR, Drago J, Horne MK. "The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice." JOURNAL OF NEUROSCIENCE. Vol. 22, no. 18. (September 2002.): 8034-8041.

Rodriguez-Sosa M, David JR, Bojalil R, Satoskar AR, Terrazas LI. "Cutting edge: Susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling." JOURNAL OF IMMUNOLOGY. Vol. 168, no. 7. (April 2002.): 3135-3139.

Costa CHN, Stewart JM, Gomes RBB, Garcez LN, Ramos PKS, Bozza M, Satoskar A, Dissanayake S, Santos RS, Silva MRB, Shaw JJ, David JR, Maguire JH. "Asymptomatic human carriers of Leishmania chagasi." AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. Vol. 66, no. 4. (April 2002.): 334-337.

Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, Collins M, Grusby MJ. "Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells." JOURNAL OF EXPERIMENTAL MEDICINE. Vol. 196, no. 7. (October 2002.): 969-977.

Greenwald RJ, McAdam AJ, van der Woude D, Satoskar AR, Sharpe AH. "Cutting edge: Inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis." JOURNAL OF IMMUNOLOGY. Vol. 168, no. 3. (February 2002.): 991-995.

Hattori H, Okano M, Yamamoto T, Yoshino T, Yamashita Y, Watanabe T, Satoskar AR, Harn DA, Nishizaki K. "Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice." CLINICAL AND EXPERIMENTAL ALLERGY. Vol. 32, no. 6. (June 2002.): 951-959.

Rodriguez-Sosa M, Rosas LE, Terrazas LI, Lu B, Gerard C, Satoskar AR. "CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection." IMMUNOLOGY AND CELL BIOLOGY. Vol. 81, no. 2. (April 2003.): 114-120.

Rodriguez-Sosa M, Rosas LE, David JR, Bojalil R, Satoskar AR, Terrazas LI. "Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps." INFECTION AND IMMUNITY. Vol. 71, no. 3. (March 2003.): 1247-1254.

Rosas LE, Keiser T, Pyles R, Durbin J, Satoskar AR. "Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 33, no. 7. (July 2003.): 1799-1805.

Rodriguez-Sosa M, Satoskar AR, David JR, Terrazas LI. "Altered T helper responses in CD40 and interleukin-12 deficient mice reveal a critical role for Th1 responses in eliminating the helminth parasite Taenia crassiceps." INTERNATIONAL JOURNAL FOR PARASITOLOGY. Vol. 33, no. 7. (July 2003.): 703-711.

Wang NH, Satoskar A, Faubion W, Howie D, Okamoto S, Feske S, Gullo C, Clarke K, Sosa MR, Sharpe AH, Terhorst C. "The cell surface receptor SLAM controls T cell and macrophage functions." JOURNAL OF EXPERIMENTAL MEDICINE. Vol. 199, no. 9. (May 2004.): 1255-1264.

Pan JH, Sukhova GK, Yang JT, Wang B, Xie T, Fu HX, Zhang X, Satoskar AR, David JR, Metz CN, Bucala R, Fang K, Simon DI, Chapman HA, Libby P, Shi GP. "Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice." CIRCULATION. Vol. 109, no. 25. (June 2004.): 3149-3153.

Rodriguez-Sosa M, Saavedra R, Tenorio EP, Rosas LE, Satoskar AR, Terrazas LI. "A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps." INFECTION AND IMMUNITY. Vol. 72, no. 8. (August 2004.): 4552-4560.

Damico N, Satoskar AR, David JR, Whitacre CC. "Macrophage migration inhibitory factor (mif) plays a role in the relapses of experimental autoimmune encephalomyelitis (eae)." FASEB JOURNAL. Vol. 175, no. 9. (November 2005.): 5611-5614.

Okano M, Hattori H, Yoshino T, Sugata Y, Yamamoto M, Fujiwara T, Satoskar AA, Satoskar AR, Nishizaki K. "Nasal exposure to Staphylococcal enterotoxin enhances the development of allergic rhinitis in mice." CLINICAL AND EXPERIMENTAL ALLERGY. Vol. 35, no. 4. (April 2005.): 506-514.

Powell ND, Papenfuss TL, McClain MA, Gienapp IE, Shawler TM, Satoskar AR, Whitacre CC. "Cutting edge: Macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis." JOURNAL OF IMMUNOLOGY. Vol. 175, no. 9. (November 2005.): 5611-5614.

Rosas LE, Barbi J, Lu B, Fujiwara Y, Gerard C, Sanders VM, Satoskar AR. "CXCR3(-/-) mice mount an efficient Th1 response but fail to control Leishmania major infection." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 35, no. 2. (February 2005.): 515-523.

Bhardwaj N, Rosas LE, Lafuse WP, Satoskar AR. "Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT 10 by Leishmania mexicana." INTERNATIONAL JOURNAL FOR PARASITOLOGY. Vol. 35, no. 1. (January 2005.): 75-82.

Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR. "Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice." INTERNATIONAL IMMUNOLOGY. Vol. 17, no. 10. (October 2005.): 1347-1357.

Morra M, Barrington RA, Abadia-Molina AC, Okamoto S, Julien A, Gullo C, Kalsy A, Edwards MJ, Chen G, Spolski R, Leonard WJ, Huber BT, Borrow P, Biron CA, Satoskar AR, Carroll MC, Terhorst C. "Defective B cell responses in the absence of SH2D1A." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Vol. 102, no. 13. (March 2005.): 4819-4823.

Howie D, Laroux FS, Morra M, Satoskar AR, Rosas LE, Faubion WA, Julien A, Rietdijk S, Coyle AJ, Fraser C, Terhorst C. "Cutting edge: The SLAM family receptor Ly108 controls T cell and neutrophil functions." JOURNAL OF IMMUNOLOGY. Vol. 174, no. 10. (May 2005.): 5931-5935.

Rosas LE, Snider HM, Barbi J, Satoskar AA, Lugo-Villarino G, Keiser T, Papenfuss T, Durbin JE, Radzioch D, Glimcher LH, Satoskar AR. "Cutting edge: STAT1, and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani." JOURNAL OF IMMUNOLOGY. Vol. 177, no. 1. (July 2006.): 22-25.

Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, Freeman GJ, Sharpe AH. "PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 36, no. 1. (January 2006.): 58-64.

Hattori H, Okano M, Kariya S, Nishizaki K, Satoskar AR. "Signals through CD40 play a critical role in the pathophysiology of Schistosoma mansoni egg antigen-induced allergic rhinitis in mice." AMERICAN JOURNAL OF RHINOLOGY. Vol. 20, no. 2. (March 2006.): 165-169.

Reyes JL, Terrazas LI, Espinoza B, Cruz-Robles D, Soto V, Rivera-Montoya I, Gomez-Garcia L, Snider H, Satoskar AR, Rodriguez-Sosa M. "Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection." INFECTION AND IMMUNITY. Vol. 74, no. 6. (June 2006.): 3170-3179.

Rosas LE, Satoskar AA, Roth KM, Keiser TL, Barbi J, Hunter C, de Sauvage FJ, Satoskar AR. "Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology." AMERICAN JOURNAL OF PATHOLOGY. Vol. 168, no. 1. (January 2006.): 158-169.

Lezama-Davila CM, Isaac-Marquez AP, Barbi J, Oghumu S, Satoskar AR. "17 beta-estradiol increases Leishmania mexicana killing in macrophages from DBA/2 mice by enhancing production of nitric oxide but not pro-inflammatory cytokines." AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. Vol. 76, no. 6. (June 2007.): 1125-1127.

Hattori H, Rosas LE, Okano M, Durbin J, Nishizaki K, Satoskar AR. "STAT1 is essential for the development of murine allergic rhinitis." AMERICAN JOURNAL OF RHINOLOGY. Vol. 21, (January 2007.): 241-.

Lezama-Davila CM, Isaac-Marquez AP, Zamora-Crescencio P, Ue-Encalada MR, Justiniano-Apolinar SY, del Angel-Robles L, Satoskar A, Hernandez-Rivero L. "Leishmanicidal activity of Pentalinon andrieuxii." FITOTERAPIA. Vol. 78, no. 3. (April 2007.): 255-257.

Lezama-Davila CM, Oghumu S, Satoskar AR, Isaac-Marquez AP. "Sex-associated susceptibility in humans with chiclero's ulcer: Resistance in females is associated with increased serum-levels of GM-CSF." SCANDINAVIAN JOURNAL OF IMMUNOLOGY. Vol. 65, no. 2. (February 2007.): 210-211.

Barbi J, Oghumu S, Lezama-Davila CM, Satoskar AR. "IFN-γ and STAT1 pathway are required for efficient induction of CXCR3 on CD4+ but not CD8+ T cell." BLOOD. Vol. 110, (January 2007.): 2215-.

Barbi J, Oghumu S, Rosas LE, Carlson T, Lu B, Gerard C, Lezama-Davila CM, Satoskar AR. "Lack of Cxcr3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani." JOURNAL OF INFECTIOUS DISEASES. Vol. 195, no. 11. (January 2007.): 1713-1717.

Lezama-Davila CM, Satoskar AR, Uc-Encalada M, Isaac-Marquez R, Isaac-Marquez AP. "Leishmanicidal activity of artemisinin, deoxoartemisinin, artemether and arteether." NATURAL PRODUCT COMMUNICATIONS. Vol. 2, no. 1. (January 2007.): 1-4.

Hattori H, Rosas LE, Okano M, Durbin JE, Nishizaki K, Satoskar AR. "STAT1 is involved in the pathogenesis of murine allergic rhinitis." AMERICAN JOURNAL OF RHINOLOGY. Vol. 21, no. 2. (March 2007.): 241-247.

Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. "Expression and localization of hepcidin in macrophages: A role in host defense against tuberculosis." JOURNAL OF LEUKOCYTE BIOLOGY. Vol. 82, no. 4. (October 2007.): 934-945.

Barbi J, Oghumu S, Lezama-Davila CM, Satoskar AR. "IFN-gamma and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4(+) but not CD8(+) T cells." BLOOD. Vol. 110, no. 6. (September 2007.): 2215-2216.

Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG. "Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury." JOURNAL OF NEUROCHEMISTRY. Vol. 102, no. 1. (July 2007.): 37-50.

Van Zandt KE, Sow FB, Florence WC, Zwilling BS, Satoskar AR, Schlesinger LS, Lafuse WP. "The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome." JOURNAL OF LEUKOCYTE BIOLOGY. Vol. 84, no. 3. (September 2008.): 689-700.

Barbi J, Cummings HE, Lu B, Oghumu S, Rueckle T, Rommel C, Lafuse W, Whitacre CC, Satoskar AR. "PI3Kgamma (PI3K gamma) is essential for efficient induction of CXCR3 on activated T cells." BLOOD. Vol. 112, no. 8. (October 2008.): 3048-3051.

Barbi J, Brombacher F, Satoskar AR. "T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation." JOURNAL OF IMMUNOLOGY. Vol. 181, no. 7. (October 2008.): 4613-4620.

Roth KM, Oghumu S, Satoskar AA, Gunn JS, van Rooijen N, Satoskar AR. "Respiratory infection with Francisella novicida induces rapid dystrophic cardiac calcinosis (DCC)." FEMS IMMUNOLOGY & MEDICAL MICROBIOLOGY. Vol. 53, no. 1. (June 2008.): 72-78.

Lezama-Davila CM, Isaac-Marquez AP, Barbi J, Cummings HE, Lu B, Satoskar AR. "Role of phosphatidylinositol-3-kinase-gamma (PI3K gamma)-mediated pathway in 17 beta-estradiol-induced killing of L-mexicana in macrophages from C57BL/6 mice." IMMUNOLOGY AND CELL BIOLOGY. Vol. 86, no. 6. (August 2008.): 539-543.

Flores M, Saavedra R, Bautista R, Viedma R, Tenorio EP, Leng L, Sanchez Y, Juarez I, Satoskar AA, Shenoy AS, Terrazas LI, Bucala R, Barbi J, Satoskar AR, Rodriguez-Sosa M. "Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii." FASEB JOURNAL. Vol. 22, no. 10. (October 2008.): 3661-3671.

Isaza CE, Zhong X, Rosas LE, White J, Chen RPY, Liang GF, Chan SI, Satoskar AR. "Leishmania major carboxypeptidase: A proposed role in pathogens." BIOCHEMICAL & BIOPHYSICAL RESEARCH COMMUNICATIONS. Vol. 373, (January 2008.): 25-.

Roth KM, Gunn JS, Lafuse W, Satoskar AR. "Francisella inhibits STAT1-mediated signaling in macrophages and prevents activation of antigen-specific T cells." INTERNATIONAL IMMUNOLOGY. Vol. 21, no. 1. (January 2009.): 19-28.

Barbi J, Snider HM, Bhardwaj N, Lezama-Davila CM, Durbin JE, Satoskar AR. "Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection." FASEB JOURNAL. Vol. 23, no. 11. (November 2009.): 3990-3999.

Sow FB, Alvarez GR, Gross RP, Satoskar AR, Schlessinger LS, Zwilling BS, Lafuse WP. "Role of STAT1, NF-kappa B, and C/EBP beta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma." JOURNAL OF LEUKOCYTE BIOLOGY. Vol. 86, no. 5. (November 2009.): 1247-1258.

Martin J, Duncan FJ, Keiser T, Shin S, Kusewitt D, Oberyszyn T, Satoskar AR, VanBuskirk AM. "Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) induced non-melanoma skin cancer (NMSC)." FASEB Journal. Vol. 23, no. 3. (March 2009.): 720-730.

Snider H, Lezama-Davila C, Alexander J, Satoskar AR. "Sex hormones and modulation of immunity against leishmaniasis." NEUROIMMUNOMODULATION. Vol. 16, no. 2. (January 2009.): 106-113.

Cummings HE, Tuladhar R, Satoskar AR. "Cytokines and their STATs in cutaneous and visceral leishmaniasis." JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. Vol. 1, (January 2010.): 294389-.

Isaac-Marquez A, McChesney JI, Nanayakara NPD, Satoskar AR, Lezama-Davila CM. "Leishmanicidal activity of racemic +/- 8-[4-Amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline." NATURAL PRODUCT COMMUNICATIONS. Vol. 5, no. 3. (March 2010.): 387-390.

Bumb RA, Mehta RD, Ghiya BC, Jakhar R, Prasad N, Soni P, Lezama-Davila C, Satoskar AR. "Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous leishmaniasis in India." BRITISH JOURNAL OF DERMATOLOGY. Vol. 163, no. 4. (October 2010.): 854-858.

Sanchez-Zamora Y, Terrazas LI, Vilches-Flores A, Leal E, Juarez I, Whitacre C, Kithcart A, Pruitt J, Sielecki T, Satoskar AR, Rodriguez-Sosa M. "Macrophage migration inhibitory factor (MIF) is a therapeutic target in treatment of non-insulin dependent diabetes mellitus (NIDDM)." FASEB JOURNAL. Vol. 24, no. 7. (July 2010.): 2583-2590.

Oghumu S, Lezama-Davila CM, Isaac-Marquez AP, Satoskar AR. "Role of chemokines in regulation of immunity against leishmaniasis." EXPERIMENTAL PARASITOLOGY. Vol. 126, no. 3. (November 2010.): 389-396.

Reyes JL, Terrazas CA, Alonso-Trujillo J, Rooijen NV, Satoskar AR, Terrazas LI.. "Early removal of alternatively activated macrophages leads to Taenia crassiceps cysticercosis clearance in vivo." INTERNATIONAL JOURNAL FOR PARASITOLOGY. Vol. 40, no. 6. (May 2010.): 731-742.

Tuladhar R, Natarajan G, Satoskar AR. "Role of co-stimulation in leishmaniasis." INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. Vol. 7, no. 9. (January 2011.): 1382-1390.

Reyes JL, Gonzalez MI, Ledesma-Soto Y, Satoskar AR, Terrazas LI. "TLR2 mediates immunity to experimental cysticercosis." INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. Vol. 7, no. 9. (January 2011.): 1323-1333.

Malu DT, Belanger B, Desautels F, Kelendji K, Dalko E, Sanchez-Dardon J, Leng L, Bucala R, Satoskar AR, Scorza T. "Macrophage migration inhibitory factor: A downregulator of early T cell-dependent IFN-gamma responses in plasmodium chabaudi adami (556 KA)-infected mice." JOURNAL OF IMMUNOLOGY. Vol. 186, no. 11. (June 2011.): 6271-6279.

Kulkarni MM, Barbi J, McMaster WR, Gallo RL, Satoskar AR, McGwire BS. "Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection." CELLULAR MICROBIOLOGY. Vol. 13, no. 6. (June 2011.): 913-923.

Prasad N, Ghiya BC, Bumb RA, Kaushal H, Saboskar AA, Lezama-Davila CM, Salotra P, Satoskar AR. "Heat, oriental sore, and HIV." LANCET. Vol. 377, no. 9765. (February 2011.): 610-610.

Bumb RA, Satoskar AR. "Radiofrequency-induced heat therapy as first-line treatment for cutaneous leishmaniasis." EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. Vol. 9, no. 6. (June 2011.): 623-625.

Khandelwal K, Bumb RA, Mehta RD, Kaushal H, Lezama-Davila C, Salotra P, Satoskar AR. "Case report: A patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India." AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. Vol. 85, no. 1. (July 2011.): 64-65.

Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, Narula V, Perry K, Hazey J, Kampfrath T, Kollengode M, Sun Q, Satoskar AR, Lumeng C, Moffatt-Bruce S, Rajagopalan S. "Visceral adipose inflammation in obesity is associated with critical alterations in T regulatory cell numbers." PLOS ONE. Vol. 6, no. 1. (January 2011.): e16376-.

Cummings HE, Barbi J, Reville P, Oghumu S, Zorko N, Sarkar A, Keiser TL, Lu B, Rueckle T, Varikuti S, Lezama-Davila C, Wewers MD, Whitacre C, Radzioch D, Rommel C, Seveau S, Satoskar AR. "Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Vol. 109, no. 4. (January 2012.): 1251-1256.

Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DAA. "The composition and signaling of the IL-35 receptor are unconventional." NATURE IMMUNOLOGY. Vol. 13, no. 3. (March 2012.): 290-U115.

Ahuja AA, Bumb RA, Mehta RD, Prasad N, Tanwar RK, Satoskar AR. "Successful treatment of canine cutaneous leishmaniasis using radio-frequency induced heat (RFH) therapy." THE AMERICAN JOURNAL OF TROPICAL MEDICINE & HYGIENE. Vol. 87, no. 2. (August 2012.): 261-263.

Smith KM, Guerau-de-Arellano M, Costinean S, Williams JL, Bottoni A, Cox GM, Satoskar AR, Croce CM, Racke MK, Lovett-Racke AE, Whitacre CC. "miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis." JOURNAL OF IMMUNOLOGY. Vol. 189, no. 4. (August 2012.): 1567-1576.

Pan L, Terrazas C, Lezama-Davila CM, Rege N, Gallucci JC, Satoskar AR, Kinghorn AD. "Cordifolide A, a sulfur-containing clerodane diterpene glycoside from tinospora cordifolia." ORGANIC LETTERS. Vol. 14, no. 8. (April 2012.): 2118-2121.

Khandelwal K, Aara N, Ghiya BC, Bumb RA, Satoskar AR. "Centro-facial pigmentation in asymptomatic congenital chikungunya viral infection." JOURNAL OF PAEDIATRICS AND CHILD HEALTH. Vol. 48, no. 6. (June 2012.): 542-543.

Alexander JK, Cox GM, Tian JB, Zha AM, Wei P, Kigerl KA, Reddy MK, Dagia NM, Sielecki T, Zhu MX, Satoskar AR, McTigue DM, Whitacre CC, Popovich PG. "Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress." EXPERIMENTAL NEUROLOGY. Vol. 236, no. 2. (August 2012.): 351-362.

Pan L, Lezama-Davila CM, Isaac-Marquez AP, Calomeni EP, Fuchs JR, Satoskar AR, Kinghorn AD. "Sterols with antileishmanial activity isolated from the roots of Pentalinon andrieuxii." PHYTOCHEMISTRY. Vol. 82, (October 2012.): 128-135.

Deiuliis JA, Kampfrath T, Zhong J, Oghumu S, Maiseyeu A, Chen LC, Sun Q, Satoskar AR, Rajagopalan S. "Pulmonary T cell activation in response to chronic particulate air pollution." AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. Vol. 302, no. 4. (February 2012.): L399-L409.

Lezama-Davila CM, Patricia IA, Kapadia G, Owens K, Oghumu S, Beverley S, Satoskar AR. "Leishmanicidal Activity of Two Naphthoquinones against Leishmania donovani." BIOLOGICAL & PHARMACEUTICAL BULLETIN. Vol. 35, no. 10. (October 2012.): 1761-1764.

Lizotte J, Abed Elie, Signor C, Malu DT, Cuevas J, Kevorkova O, Sanchez-Dardon J, Satoskar A, Scorza T, Jumarie C, Moreau R. "Expression of macrophage migration inhibitory factor by osteoblastic cells: Protection against cadmium toxicity." TOXICOLOGY LETTERS. Vol. 215, no. 3. (December 2012.): 167-173.

Zhong J, Rao X, Deiuliis J, Braunstein Z, Narula V, Hazey J, Mikami D, Needleman B, Satoskar AR, Rajagopalan S. "A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation." DIABETES. Vol. 62, no. 1. (January 2013.): 149-157.

Gupta G, Oghumu S, Satoskar AR. "Mechanisms of immune evasion in Leishmaniasis." ADVANCES IN APPLIED MICROBIOLOGY, VOL 82. Vol. 82, (January 2013.): 155-184.

Lafuse WP, Story R, Mahylis J, Gupta G, Varikuti S, Steinkamp H, Oghumu S, Satoskar AR. "Leishmania donovani Infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen." PLOS ONE. Vol. 8, no. 3. (March 2013.): e59509-.

Bumb RA, Prasad N, Khandelwal K, Aara N, Mehta RD, Ghiya BC, Salotra P, Wei L, Peters S, Satoskar AR. "Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India." BRITISH JOURNAL OF DERMATOLOGY. Vol. 168, no. 5. (May 2013.): 1114-1119.

Kebede N, Oghumu S, Worku A, Hailu A, Varikuti S, Satoskar AR. "Multilocus microsatellite signature and identification of specific molecular markers for Leishmania aethiopica." PARASITES & VECTORS. Vol. 6, (June 2013.): 160-.

Khandelwal K, Bumb RA, Mehta RD, Ghiya BC, Satoskar AR. "Long-term efficacy of radiofrequency ablation in treatment of common and palmo-plantar warts." AUSTRALASIAN JOURNAL OF DERMATOLOGY. Vol. 54, no. 4. (November 2013.): 307-309.

Duong AD, Sharma S, Peine KJ, Gupta G, Satoskar AR, Bachelder EM, Wyslouzil BE, Ainsie KM. "Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis." MOLECULAR PHARMACEUTICS. Vol. 10, no. 3. (March 2013.): 1045-1055.

Oghumu S, Satoskar AR. "PI3K-? inhibitors in the therapeutic intervention of diseases caused by obligate intracellular pathogens." COMMUNICATIVE & INTEGRATIVE BIOLOGY. Vol. 6, no. 2. (March 2013.): e23360-.

Terrazas CA, Alcantara-Hernandez M, Bonifaz L, Terrazas LI, Satoskar AR. "Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway." FASEB JOURNAL. Vol. 27, no. 11. (November 2013.): 4547-4560.

Cohen SB, Maurer KJ, Egan CE, Oghumu S, Satoskar AR, Denkers EY. "CXCR3-dependent CD4(+) T cells are required to activate inflammatory monocytes for defense against intestinal infection." PLOS PATHOGENS. Vol. 9, no. 10. (October 2013.): e1003706-.

Aara N, Khandelwal K, Bumb RA, Mehta RD, Ghiya BC, Jakhar R, Dodd C, Salotra P, Satoskar AR. "Clinco-epidemiologic study of cutaneous leishmaniasis in Bikaner, Rajasthan, India." AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. Vol. 89, no. 1. (July 2013.): 111-115.

Cox GM, Kithcart AP, Pitt D, Guan Z, Alexander J, Williams JL, Shawler T, Dagia NM, Popovich PG, Satoskar AR, Whitacre CC. "Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation." JOURNAL OF IMMUNOLOGY. Vol. 191, no. 3. (August 2013.): 1043-1054.

Dubovsky JA, Beckwith KA, Natarajan G, Woyach JA, Jaglowski S, Zhong Y, Hessler JD, Liu TM, Chang BY, Larkin KM, Stefanovski MR, Chappell DL, Frissora FW, Smith LL, Smucker KA, Flynn JM, Jones JA, Andritsos LA, Maddocks K, Lehman AM, Furman R, Sharman J, Mishra A, Caligiuri MA, Satoskar AR, Buggy JJ, Muthusamy N, Johnson AJ, Byrd JC. "Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes." BLOOD. Vol. 122, no. 15. (October 2013.): 2539-2549.

Oghumu S, Dong R, Varikuti S, Shawler T, Kampfrath T, Terrazas CA, Lezama-Davila C, Ahmer BMM, Whitacre CC, Rajagopalan S, Locksley R, Sharpe AH, Satoskar AR. "Distinct populations of innate CD8(+) T cells revealed in a CXCR3 reporter mouse." JOURNAL OF IMMUNOLOGY. Vol. 190, no. 5. (March 2013.): 2229-2240.

Arnett E, Vadia S, Nackerman CC, Oghumu S, Satoskar AR, McLeish KR, Uriarte SM, Seveau S. "The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate listeria monocytogenes intracellular survival in neutrophils." JOURNAL OF IMMUNOLOGY. Vol. 192, no. 1. (January 2014.): 234-244.

Oghumu S, Gupta G, Snider HM, Varikuti S, Terrazas CA, Papenfuss TL, Kaplan MH, Satoskar AR. "STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis." EUROPEAN JOURNAL OF IMMUNOLOGY. Vol. 44, no. 2. (February 2014.): 450-459.

Deiuliis JA, Oghumu S, Duggineni D, Zhong J, Rutsky J, Banerjee A, Needleman B, Mikami D, Narula V, Hazey J, Satoskar AR, Rajagopalan S. "CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance." OBESITY. Vol. 22, no. 5. (May 2014.): 1264-1274.

Peine KJ, Gupta G, Brackman DJ, Papenfuss TL, Ainslie KM, Satoskar AR, Bachelder EM. "Liposomal resiquimod for the treatment of Leishmania donovani infection." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. Vol. 69, no. 1. (January 2014.): 168-175.

McGwire BS, Satoskar AR. "Leishmaniasis: Clinical syndromes and treatment." QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. Vol. 107, no. 1. (January 2014.): 7-14.

Oghumu S, Bracewell A, Nori U, Maclean KH, Balada-Lasat JM, Brodsky S, Pelletier R, Henry M, Satoskar AR, Nadasdy T, Satoskar AA. "Acute pyelonephritis in renal allografts-A new role for microRNAs?." TRANSPLANTATION. Vol. 97, no. 5. (March 2014.): 559-568.

Lezama-Dávila CM, Pan L, Isaac-Márquez AP, Terrazas C, Oghumu S, Isaac-Márquez R, Pech-Dzib M, Barbi J, Calomeni E, Parinandi N, Kinghorn AD, Satoskar AR. "Pentalinon andrieuxii root extract is effective in the topical treatment of cutaneous leishmaniasis caused by leishmania mexicana." PHYTOTHERAPY RESEARCH. Vol. 28, no. 6. (June 2014.): 909-916.

Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N. "Conundrum of pathogenesis of diabetic cardiomyopathy: Role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria." MOLECULAR AND CELLULAR BIOCHEMISTRY. Vol. 386, no. 1-2. (January 2014.): 233-249.

Walker DM, Oghumu S, Gupta G, McGwire BS, Drew ME, Satoskar AR. "Mechanisms of cellular invasion by intracellular parasites." CELLULAR AND MOLECULAR LIFE SCIENCES. Vol. 71, no. 7. (April 2014.): 1245-1263.

Kithcart AP, Cox GM, Sielecki T, Short A, Pruitt J, Papenfuss T, Shawler T, Gienapp I, Satoskar AR, Whitacre CC. "A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease." FASEB Journal. -.

 

Presentations

"Mechanisms of sex-determined susceptibility to L. mexicana." Presented at Annual Meeting of British Section of Society for Protozoology, Lancaster. (January 1993)

"Mechansims of sex-determined resistance to L. mexicana." Boston, Massachussetts, US|USA. (January 1995)

"Distinct role of IL-4 in regulating immune response during visceral and cutaneous leishmaniasis." Wurzburg, DE|DEU. (January 1995)

"Distinct role of IL-4 in regulating immune response during visceral and cutaneous leishmaniasis." Frieburg, DE|DEU. (January 1995)

"Distinct role of IL-4 in regulating immune response during visceral and cutaneous leishmaniasis." Basel, CH|CHE. (January 1995)

"IL-4 is involved in pathogenesis of cutaneous leishmanaisis caused by L. mexicana." Presented at Summer Course "Immunity to intracellular bacteria and parasites", Positano, IT|ITA. (August 1995)

"Leishmania spp: Models of intracellular parasitsm." Mumbai, IN|IND. (January 1996)

"Role of IL-4 in cutaneous and visceral leishmaniasis." Presented at Royal Society of Tropical Medicine and Hygiene, Regional Meeting, Edinburgh. (January 1996)

"Leishmania spp: Models of intracellular parasitsm." Mumbai, IN|IND. (January 1996)

"Distinct roles of IL-4 in determining outcome of visceral and cutaneous leishmanaisis." Presented at Annual Meeting of British Section of Society for Protozoology, London. (January 1996)

"STAT6 signaling plays a critical role in pathogenesis of CL caused by L. mexicana." Presented at 47th Annual Meeting of the American Society for Tropical Medicine and Hygiene, Orlando, FL, US|USA. (January 1997)

"NK cells are not required for resolution of cutaneous leishmaniasis caused by L. major." Presented at First Woods Hole Immunoparasitology Meeting, Woods Hole, Massachussets, US|USA. (January 1997)

"Immune mechanisms mediating gender-associated resistance to leishmaniasis." Boston, Massachussetts, US|USA. (January 1997)

"Mice deficient for migration inhibitory factor (MIF-/-) become susceptible to L. major." Presented at Second Woods Hole Immunoparasitology Meeting, Woods Hole, MA, US|USA. (January 1998)

"Roles of Th2-type cytokines in regulation of host responses during leishmanaisis." Okayama, JP|JPN. (January 1999)

"Mice lacking NK cells mount an efficient Th1 response and control CL caused by L. major; STAT6 signaling pathway is involved in mediating susceptibility to CL caused by L. mexicana." Presented at Experimental Biology 99, San Francisco, CA, US|USA. (January 1999)

"Mechanisms of immunoregulation in leishmaniasis." Osaka, JP|JPN. (January 1999)

"Control of cutaneous L. mexicana infection in L-selectin gene deficient mice.." Presented at Third Woods Hole Immunoparasitology Meeting, Woods Hole, Massachussetts, US|USA. (January 1999)

"Mechansims of immunity in leishmaniasis: A complex puzzle." Columbus, OH, US|USA. (February 2000)

"Mechansims of immunity in leishmaniasis: A complex puzzle." Montreal, CA|CAN. (February 2000)

"Role of IL-4 and STAT6 signaling pathway in pathogenesis of CL caused by L. mexicana." Presented at Oxford 2000, Annual Combined meeting of ASTMH, British Society for Protozoology, Oxford. (January 2000)

"Mechansims of immunity in leishmaniasis: A complex puzzle." Rio De Janeiro, BR|BRA. (January 2000)

"Mechansims of IL-4 and STAT6-mediated susceptibility to L. mexicana." Cape Town, ZA|ZAF. (January 2000)

"MIF: A critical mediator of inflammation and immunity." Hamilton, CA|CAN. (January 2001)

"Mechanisms of immunoregulation in leishmanaisis." Montreal, CA|CAN. (January 2001)

"Mechanisms of immunity in leishmaniasis." Baltimore, MD. (January 2002)

"Cytokines and regulation of immunity against leishmanaisis." Cape Town, ZA|ZAF. (January 2002)

"Distinct roles of IL-4 and IL-13 in cutaneoues and viscerla leishmanaisis." Presented at IL-13 and related factors in inflammation and disease, Cape Town, ZA|ZAF. (March 2003)

"Mechanisms of immunity in visceral and cutaneous leishmaniasis." Muscat, OM|OMN. (January 2004)

"Distinct roles of STAT1 and T-bet in determining outcome of visceral leishmaniasis." Keele, GB|GBR. (January 2004)

"STAT-1 mediated signaling induces hepatic immunopathology and also mediates susceptibility to L. donovani." Presented at Ninth Woods Hole Immunoparasitology Meeting, Woods Hole, Massacussetts, US|USA. (January 2005)

"Role of sex hormones in regulation of immunity to L. mexicana." Presented at 54th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, D.C., US|USA. (January 2005)

"Role of chemokine in mediating immunity against cutaneous leishmaniasis." Presented at Ohio American Society for Microbiology Branch Meeting, Delaware, OH, US|USA. (January 2005)

"Mechanisms of immunity to Leishmania: A complex puzzle." New York, NY. (January 2005)

"Distinct roles of STAT1 and T-bet in determining outcome of visceral leishmaniasis." Oxford, OH, US|USA. (January 2005)

"Distinct roles of STAT1 and T-bet in determining outcome of visceral leishmaniasis." Pune, IN|IND. (January 2005)

"Mechanisms of immunity and immune evasion in protozoan infections." Presented at Annual Meeting of Japanese Society of Otolaryngology, Okayama, JP|JPN. (March 2005)

"Distinct roles of TH1-specific transcription factors stat1 and T-bet in regulating immunity to leishmania." Hannover, NH. (January 2006)

"Distinct roles of STAT1 and T-bet in visceral leishmaniasis." Montreal, CA|CAN. (January 2006)

"Distinct roles of STAT1 and T-bet in visceral leishmaniasis." Mexico City, MX|MEX. (January 2006)

"Distinct roles of STAT1 and T-bet in determining outcome of viscerla leishmaniasis." Presented at 2nd Symposium in Immunoparasitology, Yaxtho, MX|MEX. (October 2006)

"Distinct roles of STAT1 and T-bet in visceral leishmaniasis." Hobart, AU|AUS. (June 2006)

"Distinct roles of STAT1 and T-bet in visceral leishmaniasis." Melbourne, AU|AUS. (June 2006)

"Role of MIF in pathogenesis of EAE." Geneva, CH|CHE. (January 2007)

"Distinct roles of STAT1 and T-bet in visceral leishmaniasis." Dublin, IE|IRL. (January 2007)

"Differential role of STAT1 in regulating immunity against visceral and cutaneous leishmanaisis." Presented at Mexicao Society for Parasitology Regional Seminar Series, Mexico City, MX|MEX. (January 2007)

"Mechanisms of immunoregulation in visceral and cutaneous leishmanaisis." Edinburgh, GB|GBR. (October 2007)

"Targeting PI3Kg to block entry of Leishmania into phagocytes: A new strategy to treat cutaneous leishmaniasis." Presented at VIII Central American and Caribbean Congress of Parasitology and Tropical Medicine, Havana, CU|CUB. (December 2007)

"Targeting phosphoinositide 3-kinase gamma in treatment of cutaneous leishmaniasis caused by L. mexicana.." Presented at Immunology of Health and Disease, Cape Town, ZA|ZAF. (March 2008)

"Denying access to safe havens to prevent insurgency: A new strategy for treating infections caused by intracellular pathogens." Mexico City, MX|MEX. (May 2008)

"Denying access to safe havens to prevent insurgency: A new strategy for treating infections caused by intracellular pathogens." Bethesda, MD. (December 2008)

"Role of sex hormones in regulation of immunity to leishmaniasis." Presented at 7th Congress of the International Society for Neuroimmunomodulation, Rio de Janeiro, BR|BRA. (June 2008)

"Role of sex hormones in immunity to leishmaniasis." Presented at Organization for the study of sex differences (OSSD) 2nd Annual Meeting, New Orleans, LA, US|USA. (June 2008)

"Role of MIF in immunity and inflammation." Mumbai, IN|IND. (June 2008)

"Denying access to safe havens to prevent insurgency: A new strategy for treating infections caused by intracellular pathogens." Panama City, PA|PAN. (June 2008)

"Immunological defects in BALB/c mice: How many more to find?." Presented at 3rd Symposium on Immunoparasitology, Ixtapan de la Sal, MX|MEX. (October 2008)

"Denying access to safe haves to prevent insurgency: A novel strategy to treat infections caused by Leishmania." State Park, PA. (October 2008)

"Mechanisms of immunoregulation in leishmaniasis." Lucknow, IN|IND. (February 2009)

"Denying access to safe haves to prevent insurgency: A novel approach to treat leishmaniasis." Tampa, FL, US|USA. (February 2009)

"Denying access to safe havens: A novel strategy to treat leishmaniasis." Presented at Indo-US Symposium on Bioinformatics and Intracellular pathogens, New Delhi, IN|IND. (February 2009)

"Careers in biomedical research." New Delhi, IN|IND. (February 2009)

"Diagnosis and clincial management of leishmanaisis." Presented at Continued Medical Education Course, Bikaner, IN|IND. (June 2009)

"Denying access to safe haves by targeting PI3Kg: A new strategy to treat leishmanaisis." El Paso, TX, US|USA. (June 2009)

"Role of PI3Ks in pathogenesis of cutaneous leishmaniasis caused by L. mexicana." Anchorage, AK, US|USA. (March 2009)

"Denying access to safe havens to prevent insurgency: A novel strategy to treat infections caused by intracellular pathogens." Calgary, CA|CAN. (March 2009)

"Distinct roles of STAT1 in visceral and cutaneous leishmaniasis." Mexico City, MX|MEX. (January 2009)

"Denying access to safe haves to prevent insurgency: A novel approach to treat leishmaniasis." Ithaca, NY. (January 2009)

"Denying access to safe haves by targeting PI3Kg: A new strategy to treat leishmanaisis." Perth, AU|AUS. (May 2009)

"Denying access to safe havens to prevent insurgency: A new strategy for treating infections caused by intracellular pathogens." Brisbane, AU|AUS. (January 2009)

"Denying access to safe havens by targeting PI3Kg: A new strategy to treat leishmanaisis." College Park, MD. (January 2009)

"Targeting PI3Kg: A novel strategy to treat infections caused by obligate intracellular pathogens." Presented at WorldLeish 4, Lucknow, IN|IND. (February 2009)

"STAT1 in T cells palys a critical role in immunity against L. major by mediating recrutiment of Th1 cells to the site of infection." Presented at WorldLeish 4, Lucknow, IN|IND. (February 2009)

"Distinct roles of STAT1 in determining outcomes of CL and VL." Baltimore, MD, US|USA. (April 2009)

"Role of STAT1 signaling in immunity to leishmanaisis." Presented at XVIII National Congress of Parasitology (CONAPAR 2009) fo Mexican Society for Parasitology, Aguascalientes, MX|MEX. (October 2009)

 

Professional Activities

2001 - present Adhoc Reviewer for Research Grants. National Research Foundation, South Africa.
2002 - present Reviewer for Research Grants. Cape Biotech Initiative, South Africa.
2003 - present Reviewer for Research Grants. Sheikh Hamdan Medical Research Grant Foundation, Dubai, UAE.
2003 - present Adhoc Reviewer for Leishmania Special Study Section. NIH.
2004 - present Ad hoc Reviewer for Research Grants. Uniformed Services University for Health Sciences.
2004 - present Adhoc Reviewer for IDM Study Section. NIH.
2004 - present Adhoc Reviewer for PTHE Study Section. NIH.
2005 - present Ad hoc Reviewer, Program Projects. Wellcome Trust, UK.
2005 - present Adhoc Reviewer for IDM Study Section. NIH.
2006 - present External Examiner for Ph.D.. McGill University, Montreal, Canada.
2006 - present External Examiner for Masters and Ph.D.. University of Cape Town, South Africa.
2006 - present Adhoc Reviewer, Leishmaniasis Panel. US Army Medical Research and Materiel Command’s (USAMRMC) Military Infectious Disease Research Program (MIDRP).
2006 - present Adhoc Reviewer for Tropical Medicine Research Centers RFA Study Section. NIH.
2007 - present Adhoc Reviewer, Viral vaccine panel. Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), Department of Defense.
2007 - present Adhoc Reviewer, Leishmaniasis Panel. US Army Medical Research and Materiel Command’s (USAMRMC) Military Infectious Disease Research Program (MIDRP).
2007 - present External Examiner for Ph.D.. Sanjay Gandhi Postgraduate Institute for Medical Sciences, Lucknow, India.
2007 - present Examiner for Ph.D.. University of Pune, India.
2007 - present Promotion and Tenure Review. Indian Institute of Technology, Kharagpur, India.
2007 - present Ad hoc Reviewer, Program Projects. Wellcome Trust, UK.
2008 - present Adhoc Reviewer for Research Grants. US Army Medical Research and Materiel Command’s (USAMRMC) Military Infectious Disease Research Program (MIDRP).
2008 - present Promotion and Tenure Review. School of Medicine, Trinity College, Dublin, Ireland.
2008 - present Adhoc Reviewer for Research Grants. US Airforce Medical Research Program.
2008 - present Grant Reviewer, Leishmaniasis Panel. American Institute of Biological Sciences and Department of Defense.
2009 - present Adhoc Reviewer for NIAID Integrative and Collaborative Approaches to Research SEP. NIH.
2009 - present Teaching. WWAMI Program in Medicine, University of Alaska, Anchorage.
2009 - present Adhoc Reviewer for International Collaborations for Infectious Disease Research (ICIDR), Parasitology SEP. NIH.
2010 - present Swiss National Science Foundation.
2010 - present Visiting Professor. University of Anchorage, Alaska, School of Medicine WAMMI Program. Anchorage, AK.
2003 Adhoc Reviewer for TMP Study Section. NIH.